Precision Approaches in Radiation Synthetic Combinations (PAIRS, RP1 Clinical Trial Optional)
Agency: National Institutes of Health
- 93.395 -- Cancer Treatment Research
Forecasted opportunityLast Updated: May 13, 2026
Important dates
- Forecasted post date: June 1, 2026
- Forecasted application due date: November 11, 2026
- Forecasted award date: July 1, 2027
- Forecasted project start date: July 1, 2027
- Fiscal Year: 2027
Award details
- Expected project funding: Not specified
- Expected awards: Not specified
Award min.
Not specified
Award max.
Not specified
- Funding opportunity number:PAR-26-152
- Cost sharing or matching requirement:No
- Funding instrument type:
- Grant
- Opportunity Category:Discretionary
- Opportunity Category Explanation:Not specified
- Category of Funding Activity:
- Health
- Category Explanation:Not specified
History
- Forecast posted date: March 3, 2026
- Archive date: Not specified
- Version: 1
Summary
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits research projects that investigate actionable synthetic vulnerabilities that can be conditionally paired with tumor responses to radiation therapy. The goal of the Precision Approaches in Radiation Synthetic Combinations (PAIRS) program is to develop radiation-synthetic combination strategies and facilitate their adoption into the precision medicine toolkit toward building new and effective anticancer treatments. Early synthetic lethality–based therapeutic strategies in oncology primarily focused on targeting fixed mutations or genomic abnormalities. More recently, however, it has become clear that clinical benefit is often determined by context-dependent vulnerabilities arising from the intrinsic mutational landscape and adaptive tumor responses.
This NOFO is unique in its scope, supporting innovative cancer therapy strategies that explicitly exploit context-dependent effects of radiation therapy (RT) using drug-radiation combinations. The central premise of the PAIRS is that these conditional RT-induced responses can be leveraged to create or enhance actionable vulnerabilities that synergize with molecularly targeted agents for better outcomes. A defining feature of PAIRS is its emphasis on precision, scientific rigor, and reproducibility, aligned with NIH’s scientific priorities. Radiation effects are clinically titratable through advances in delivery accuracy and flexibility, including dose, schedule, and spatial targeting. These capabilities enable the rational design of conditional RT-synthetic combination strategies that preferentially exploit tumor-specific essentialities while sparing normal tissues, thereby enhancing the therapeutic index by optimizing biological response. This NOFO consolidates the prior exploratory/developmental and research project funding opportunities to streamline the application process and maintain momentum in developing approaches that target actionable vulnerabilities within the defined radiation research scope. The applicants may submit either for exploratory/developmental research projects with a project period of up to 2 years or for research projects with a project period of 4 to 5 years.
Eligibility
Business
- For-profit organizations other than small businesses
- Small businesses
Education
- Private institutions of higher education
- Public and state institutions of higher education
- Independent school districts
Nonprofit
- Nonprofits non-higher education without 501(c)(3)
- Nonprofits non-higher education with 501(c)(3)
- Other Native American tribal organizations
Government
- City or township governments
- County governments
- Special district governments
- Federally recognized Native American tribal governments
- State governments
- Public and Indian housing authorities
Miscellaneous
- Other
Additional information on eligibility
Documents
No documents are currently available.
Agency contact information
Email: Email: pairsresearchgrants@nih.gov
Email: pairsresearchgrants@nih.gov
Link to additional information
No additional information is available
